Articles

Building an AI-Fluent Organization: How Pfizer is helping colleagues understand, embrace, and apply AI

Pfizer has been utilizing artificial intelligence (AI) across our business for some time, but recent advancements in technology combined with advancements in biology are converging to create a scientific renaissance set to transform health as we know it. That reality is already upon us.According to Pfizer CEO Albert Bourla, the biggest barrier to unlock this potential is fear of the unknown. "It is not a question of technology," Bourla said in a recent conversation with Nikolai Tangen of the...

How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. Launched in February, season 6 included five episodes, each one focused on a different aspect of the fight against cancer, wrapping with last week’s season finale about AI’s impact on cancer care.All season long, each podcast episode has been accompanied by a full-length video conversation between host Dr. Raven Baxter – a molecular biologist and science educator – and one of her guests...

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.The entire organization remained focused on addressing the world’s most pressing health challenges, and 2025 was a year of significant progress toward that goal. We’ve detailed some of the highlights in our latest Annual...

The 6th Season of 'Science Will Win' Takes on Cancer

On February 4th, Pfizer observed World Cancer Day, a global effort to raise awareness of cancer and to encourage its prevention, detection, and treatment. We are on a mission to outdo cancer and make 8 breakthroughs in the fight against the disease by 2030.It all starts with education, which is why we’re excited to announce that the new season of our award-winning flagship podcast, Science Will Win, which launched today, is tackling cancer head-on with the help of expert doctors and scientists.N...

Pfizer Enters into Agreement with Walgreens to Help Eligible U.S. Adults Navigate Their Healthcare Journey

Winter is a busy time of year. The one thing you don’t want to let fall by the wayside is your health, especially with colder weather potentially bringing an increase in COVID-19, flu, and other respiratory viruses.For some adults, keeping up with their health, including understanding which vaccinations they may be eligible to receive, may feel like a daunting task. The agreement between Pfizer and Walgreens is intended to help make the process more connected and personal.We recently launched a...

Accelerating Innovation: Pfizer’s 2025 AI Festival

video-js.video-js.vjs-fluid:not(.vjs-audio-only-mode) { padding-top: 56.25%; } In late October, Pfizer colleagues around the world gathered—virtually and in person—for our second annual AI Festival Week, reaffirming our commitment to innovation and the transformative power of artificial intelligence. This year’s festival was a vibrant showcase of how AI is accelerating progress in science and healthcare, simplifying workflows, and amplifying impact for...

The Power of Knowing: Medley’s Edith Cooper Talks Equity in AI

Over the summer, Pfizer launched “The Power of Knowing,” a video series hosted by our Chief Digital and Technology Officer, Lidia Fonseca. The series explores how artificial intelligence (AI) is unlocking innovation that was previously out of reach via interviews with industry leaders at the forefront of these changes. Today we’re excited to share a new installment that touches on a topic that’s so important to Pfizer that the concept serves as one of our core values: equity.Equity may not...

Pfizer Racks Up Awards for Podcast, More

Earlier this month, Pfizer released the latest season of our flagship podcast, Science Will Win. Ranking among the top 1% of all podcasts, Science Will Win’s fifth season explores four exciting medical technologies and provides another collection of informative, provocative content around science and pharma.Award-winning content, as a matter of fact! Today we’re delighted to share some of the accolades that Science Will Win’s fourth season recently received.At the MM+M awards, the medical...

October Social Media Round-Up—Values Day, ESMO 2025, and More

It may be spooky season, but there’s nothing scary about Pfizer’s updates this month. Check out our social media channels to see the latest.Over on our corporate channels we shared highlights from ESMO 2025, spotlighted the personal stories of our Pfizer colleagues and partners, and launched new episodes of “What’s In My Lab” and “The Power of Knowing.”Meanwhile, CEO Albert Bourla announced Pfizer’s voluntary agreement with the U.S. government to lower drug costs for American patients...

Accenture CEO Talks AI’s New Frontier on The Power of Knowing

Knowledge changes everything. In a world where science, technology, and AI are converging, knowing isn’t just about information—it’s about unlocking possibilities that redefine what’s achievable for humanity. For those of us at the intersection of health and technology, this knowledge becomes action: accelerating discovery, streamlining processes, and strengthening connections that bring hope and healing to millions.That’s why we launched “The Power of Knowing,” a video series hosted by our...

Pfizer’s Flagship “Science Will Win” Podcast Returns for Season 5

We at Pfizer know that when it comes to making breakthroughs that change patients’ lives, science and technology work hand-in-hand. We’ve been investigating this intersection on our Science Will Win podcast for years, and with the launch of season five, we’re taking a close look at the future of medicine.The new season of Science Will Win, available now, explores the latest cutting-edge innovations that might soon redefine what’s possible for human health.Season five of Science Will Win, our...

Science & Innovation

Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure

Roughly one in three Americans is at risk for heart failure1, a condition where the heart can no longer effectively pump blood. And one in four will develop heart failure at some point in their lives1. Behind these statistics is a complex issue: the causes of heart failure differ widely among affected individuals. And identifying the underlying cause – especially if it’s rare – can be tricky.Among the less recognized causes is transthyretin amyloid cardiomyopathy, or ATTR-CM, which can mimic...